Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bremer

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Digestion|November 7, 2019
Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and ProgressionSebastian C B Bremer, Lena-Christin Conradi, Nicolae-Catalin Mechie, et al.
Cancers|June 24, 2022
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor PrognosisSebastian C B Bremer, Gabi Bittner, Omar Elakad, et al.
Journal of Viral Hepatitis|June 12, 2018
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapyG L Lutterkort, A Wranke, J Hengst, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 25, 2012
Chronic hepatitis e in heart transplant recipientsS Pischke, P Stiefel, B Franz, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Digestion|November 7, 2019
Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and ProgressionSebastian C B Bremer, Lena-Christin Conradi, Nicolae-Catalin Mechie, et al.
Cancers|June 24, 2022
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor PrognosisSebastian C B Bremer, Gabi Bittner, Omar Elakad, et al.
Journal of Viral Hepatitis|June 12, 2018
Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapyG L Lutterkort, A Wranke, J Hengst, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 25, 2012
Chronic hepatitis e in heart transplant recipientsS Pischke, P Stiefel, B Franz, et al.
Pageof 5